Lauren Burke

Most Recent Articles by Lauren Burke

Alectinib Approved by FDA for Non-Small Cell Lung Cancer

Alectinib Approved by FDA for Non-Small Cell Lung Cancer

By

The FDA has granted alectinib (ALECENSA) accelerated approval for the treatment of patients with non-small cell lung cancer.

Genotype-Guided Dose of Fluoropyrimidine May Decrease Toxicity

Genotype-Guided Dose of Fluoropyrimidine May Decrease Toxicity

By

Using a genotype-guided dose of fluoropyrimidine in DPYD*2A variant allele carriers significantly reduced grade 3 or higher toxicities.

Identifying, Overcoming Obstacles Related to Survivorship Care

Identifying, Overcoming Obstacles Related to Survivorship Care

By

As of 2012 in the U.S. there were 14 million cancer survivors, a number that is expected to grow to 18 million by 2022.

Cyramza Plus FOLFIRI Approved for Metastatic Colorectal Cancer

Cyramza Plus FOLFIRI Approved for Metastatic Colorectal Cancer

By

The FDA announced approval of CYRAMZA (ramucirumab) for use in combination with FOLFIRI for metastatic colorectal cancer.

POMALYST Meets Accelerated Approval Requirements for Multiple Myeloma

POMALYST Meets Accelerated Approval Requirements for Multiple Myeloma

By

POMALYST for relapsed/refractory multiple myeloma has met its accelerated approval requirements.

More Articles by Lauren Burke

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters